B-NDG hCD98HC mice
NOD.CB17-Prkdcscid Il2rgtm1Bcgen Slc3a2tm1(SLC3A2)Bcgen/Bcgen • 113117
B-NDG hCD89 mice
B-NDG hCDH17 mice

B-NDG hCD98HC mice

Catalog Number
113117
Strain Name
NOD.CB17-Prkdcscid Il2rgtm1Bcgen Slc3a2tm1(SLC3A2)Bcgen/Bcgen
Strain Background
B-NDG
NCBI gene ID
Aliases
4F2; Cd98; Ly10; Mdu1; 4F2HC; Ly-10; NACAE; Ly-m10; Mgp-2hc; gc; p64; [g]c; CD132; gamma(c); p460; scid; slip; DNAPK; DNPK1; HYRC1; XRCC7; dxnph; DOXNPH; DNAPDcs; DNA-PKcs

on this page

  • Description
  • Phenotypic analysis
  • Physiological data

Posters

View All

    Publication

      Description

      Gene Information: CD98HC, encoded by the SLC3A2 gene, is a critical type II transmembrane glycoprotein. It functions primarily as a heavy chain that covalently associates via a disulfide bond with various light chains, such as LAT1 or LAT2. 

      Protein Expression: In normal physiological conditions, CD98HC is expressed moderately across various tissues, including the kidneys, intestinal epithelium, and placenta, where it maintains regular metabolic and transport functions. However, its expression is markedly upregulated in proliferating cells, activated lymphocytes, and a wide array of human malignancies, including carcinomas and melanomas. 

      Signaling Pathway: CD98HC actively participates in intricate intracellular signaling networks by interacting directly with beta-1 and beta-3 integrins. This interaction modulates integrin-mediated signal transduction, promoting cell adhesion, migration, spreading, and survival. 

      Application: Given its prominent role in cancer cell metabolism and immune activation, CD98HC has emerged as a promising therapeutic target in oncology and immunology. CD98hc-targeting antibodies or ligands enable receptor-mediated transcytosis across the blood-brain barrier, serving as an efficient shuttle to transport therapeutic drugs, proteins, and nanoparticles directly into the central nervous system.

      Human CD98HC mRNA Expression Analysis in CD98HC Humanized B-NDG Mice
      • Mouse Cd98hc mRNA is detectable only in wild-type B-NDG mice. 
      • Human CD98HC mRNA is detectable only in homozygous CD98HC humanized B-NDG mice, but not in wild-type B-NDG mice.

      Species specific CD98HC gene expression in wild-type B-NDG mice and homozygous CD98HC humanized B-NDG mice by RT-PCR. Kidney and brain were collected from wild-type B-NDG mice (+/+) and homozygous B-NDG hCD98HC mice (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human CD98HC primers.

      Human CD98HC Protein Expression Analysis in Spleen of CD98HC Humanized B-NDG Mice

      Strain specific CD98HC expression analysis in wild-type B-NDG mice and homozygous CD98HC humanized B-NDG mice. Splenocytes were collected from wild-type B-NDG mice (+/+) and homozygous B-NDG hCD98HC mice (H/H). Protein expression was analyzed with anti-mouse CD98HC antibody (Biolegend, 128211) and anti-human CD98HC antibody (Biolegend, 315603) by flow cytometry. Mouse CD98HC was detectable in neutrophils, DCs, monocytes and macrophages of wild-type B-NDG mice, and human CD98HC was exclusively detectable in homozygous B-NDG hCD98HC mice.

      Human CD98HC Protein Expression Analysis in Bone marrow of CD98HC Humanized B-NDG Mice

      Strain specific CD98HC expression analysis in wild-type B-NDG mice and homozygous CD98HC humanized B-NDG mice. Bone marrow cells were collected from wild-type B-NDG mice (+/+) and homozygous B-NDG hCD98HC mice (H/H). Protein expression was analyzed with anti-mouse CD98HC antibody (Biolegend, 128211) and anti-human CD98HC antibody (Biolegend, 315603) by flow cytometry. Mouse CD98HC was detectable in neutrophils, DCs, monocytes and macrophages of wild-type B-NDG mice, and human CD98HC was exclusively detectable in homozygous B-NDG hCD98HC mice.

      Human CD98HC Protein Expression Analysis in Across Tissues of CD98HC Humanized B-NDG Mice

      Western blot analysis of human CD98HC protein expression in homozygous CD98HC humanized B-NDG mice. Various tissue lysates were collected from wild-type B-NDG and homozygous B-NDG hCD98HC mice (H/H), and then analyzed by western blot with species-specific anti-human CD98 antibody (Abcam, ab307587). 40 μg total protein was loaded for western blotting analysis.

      Functional Assay-Normal Hematological Profiles Analysis of CD98HC Humanized B-NDG Mice

      Complete blood count (CBC) of CD98HC humanized B-NDG mice.CD98HC humanization does not disrupt hematopoiesis or immune cell composition. Values are expressed as mean ± SD.

      Functional Assay-Normal Liver and Kidney Function Profiles Analysis of CD98HC Humanized B-NDG Mice

      Biochemical test of CD98HC humanized B-NDG mice. CD98HC humanization does not adversely affect metabolic health or organ function. Values are expressed as mean ± SD.

      Brain Orthotopic Tumor Model in CD98HC Humanized B-NDG Mice

      Growth kinetics of B-Tg(Luc-EGFP) U-87 MG tumors determined by bioluminescence imaging (BLI). B-Tg(Luc-EGFP) U-87 MG cells (1x105) were injected into the brain of B-NDG hCD98HC mice (female and male, 7-week-old, n=6). Signal intensity and body weight were measured twice a week. (A) Raw bioluminescence images. (B) Body weight. (C) Signal intensity. These results indicate that B-Tg(Luc-EGFP) U-87 MG cells (Cat. No 322265) can establish brain orthotopic tumors in B-NDG hCD98HC mice, and this strain of mice can be used for drug efficacy studies. Values are expressed as mean ± SEM.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-NDG hCD98HC mice] (Cat# 113117) was purchased from Biocytogen.